| Primary |
| Growth Hormone Deficiency |
15.2% |
| Hypopituitarism |
12.1% |
| Blood Corticotrophin Decreased |
7.8% |
| Essential Hypertension |
6.2% |
| Blood Follicle Stimulating Hormone Decreased |
5.4% |
| Blood Thyroid Stimulating Hormone Decreased |
5.4% |
| Primary Hypothyroidism |
5.2% |
| Blood Luteinising Hormone Decreased |
4.7% |
| Hypertension |
4.4% |
| Product Used For Unknown Indication |
4.1% |
| Diabetes Mellitus |
3.9% |
| Major Depression |
3.6% |
| Hypothyroidism |
3.4% |
| Renal Failure Chronic |
3.4% |
| Hypogonadism |
3.1% |
| Epilepsy |
2.8% |
| Hypogonadism Male |
2.8% |
| Analgesic Therapy |
2.3% |
| Prader-willi Syndrome |
2.3% |
| Body Height Below Normal |
1.8% |
|
| Death |
29.7% |
| Anxiety |
4.7% |
| Bone Sarcoma |
4.7% |
| Craniopharyngioma |
4.7% |
| Neoplasm Recurrence |
4.7% |
| Pituitary Tumour Benign |
4.7% |
| Sleep Apnoea Syndrome |
4.7% |
| Somnolence |
4.7% |
| Asthma |
3.1% |
| Cerebrovascular Accident |
3.1% |
| Circulatory Collapse |
3.1% |
| Convulsion |
3.1% |
| Drug Exposure During Pregnancy |
3.1% |
| Dyspnoea |
3.1% |
| Fall |
3.1% |
| Headache |
3.1% |
| Medulloblastoma Recurrent |
3.1% |
| Melas Syndrome |
3.1% |
| Nephrotic Syndrome |
3.1% |
| Pneumonia |
3.1% |
|
| Secondary |
| Diabetes Mellitus |
15.9% |
| Growth Hormone Deficiency |
15.2% |
| Hypopituitarism |
9.8% |
| Blood Corticotrophin Decreased |
6.8% |
| Hiv Infection |
6.1% |
| Product Used For Unknown Indication |
5.3% |
| Secondary Adrenocortical Insufficiency |
5.3% |
| Hypothyroidism |
4.5% |
| Acquired Immunodeficiency Syndrome |
3.8% |
| Hypogonadism |
3.8% |
| Hormone Replacement Therapy |
3.0% |
| Secondary Hypogonadism |
3.0% |
| Small For Dates Baby |
3.0% |
| Blood Thyroid Stimulating Hormone Decreased |
2.3% |
| Constipation |
2.3% |
| Diabetes Insipidus |
2.3% |
| Prader-willi Syndrome |
2.3% |
| Renal Transplant |
2.3% |
| Blood Follicle Stimulating Hormone Decreased |
1.5% |
| Blood Luteinising Hormone Decreased |
1.5% |
|
| Myocardial Infarction |
13.7% |
| Craniopharyngioma |
11.8% |
| Melas Syndrome |
11.8% |
| Sleep Apnoea Syndrome |
11.8% |
| Brain Neoplasm |
7.8% |
| Hepatoblastoma Recurrent |
5.9% |
| Suicidal Ideation |
5.9% |
| Germ Cell Cancer |
3.9% |
| Melanocytic Naevus |
3.9% |
| Muscle Hypertrophy |
3.9% |
| Cerebral Haemorrhage |
2.0% |
| Death |
2.0% |
| Dizziness |
2.0% |
| Hepatic Enzyme Increased |
2.0% |
| Hyperlipidaemia |
2.0% |
| Hypoglycaemia |
2.0% |
| Hyponatraemia |
2.0% |
| Nephrosclerosis |
2.0% |
| Osteotomy |
2.0% |
| Pituitary Tumour Benign |
2.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
38.5% |
| Juvenile Arthritis |
30.8% |
| Renal Transplant |
7.7% |
| Blood Growth Hormone |
3.8% |
| Crohn's Disease |
3.8% |
| Growth Retardation |
3.8% |
| Precocious Puberty |
3.8% |
| Prophylaxis |
3.8% |
| Puberty |
3.8% |
|
| Splenomegaly |
22.2% |
| Asphyxia |
11.1% |
| Astrocytoma |
11.1% |
| Chronic Myelomonocytic Leukaemia |
11.1% |
| Histiocytosis Haematophagic |
11.1% |
| Hypotension |
11.1% |
| Pyrexia |
11.1% |
| Renal Failure |
11.1% |
|
